SUR-1 Activators belong to a class of chemical compounds associated with the modulation or enhancement of the biological activity of Sulfonylurea Receptor 1 (SUR-1), a key regulatory protein found in the pancreatic beta cells and certain other tissues. SUR-1 is a subunit of ATP-sensitive potassium (KATP) channels, which are membrane proteins that play a critical role in regulating cellular membrane potential and insulin secretion. KATP channels consist of two subunits: SUR-1, which serves as a regulatory subunit, and Kir6.2 (in pancreatic beta cells), which forms the pore-forming subunit. The activation of SUR-1 by specific ligands leads to the closure of KATP channels, resulting in membrane depolarization and subsequent calcium influx, which triggers insulin release from pancreatic beta cells.
SUR-1 Activators are believed to interact with SUR-1, influencing its conformation or binding affinities for ligands, such as nucleotides. This interaction leads to the activation of KATP channels, causing them to close and subsequently initiating a cascade of events that regulate insulin secretion. This control over insulin release is essential for maintaining glucose homeostasis in the body, as insulin plays a crucial role in facilitating the uptake of glucose by cells and regulating blood sugar levels. By targeting SUR-1, these activators can modulate the activity of KATP channels, and their effects on insulin secretion have implications for understanding the complex regulatory mechanisms that govern glucose metabolism and pancreatic function. Research in this area provides insights into the molecular basis of insulin secretion and glucose regulation, which are critical aspects of metabolic physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Repaglinide | 135062-02-1 | sc-219959 sc-219959A sc-219959B | 100 mg 250 mg 1 g | $219.00 $422.00 $1358.00 | 3 | |
Repaglinide targets pancreatic beta cells, potentially influencing SUR-1 expression due to its role in insulin release. | ||||||
Nateglinide | 105816-04-4 | sc-394067 sc-394067A | 10 mg 25 mg | $192.00 $265.00 | ||
Nateglinide's interaction with beta cells suggests a possible impact on SUR-1 expression, linked to its insulinotropic effects. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone could affect SUR-1 expression by influencing insulin secretion pathways and beta cell metabolism. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
Acarbose, through its actions on carbohydrate metabolism, might indirectly influence SUR-1 expression in beta cells. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
1,1-Dimethylbiguanide, Hydrochloride may induce SUR-1 expression by affecting cellular metabolism and insulin secretion pathways in pancreatic beta cells. | ||||||